Cystatin C as an Early Marker of Cardiorenal Syndrome Type 1 in Patients Admitted with Acute Heart Failure. Nep. Med. Coll. J. [Internet]. 2022 Dec. 23 [cited 2026 Jul. 6];24(4):316-20. Available from: https://nepjol.info/index.php/nmcj/article/view/50586